Published February 24, 2011 | Version v1
Patent Open

COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS

  • 1. University of Chicago

Contributors

Patent applicant:

Description

The present invention relates to therapeutic combinations and methods of inhibiting the proliferation of cancerous cells, the abnormal growth of cells, and tumor cell growth using the combination of a hedgehog inhibitor with chemotherapy and/or radiation therapy. The present invention also relates to methods of enhancing the antiproliferative effect of chemotherapy and/or radiation therapy in a mammalian cancer patient undergoing either chemotherapy or radiation or a combination of radiation and chemotherapy by co-administering a therapeutically amount of a hedgehog inhibitor, concurrently or sequentially, with the chemotherapy and/or radiation therapy.

Files

US20110046211.pdf

Files (973.1 kB)

Name Size Download all
md5:d4c40e203ce1c9fb3017f5d40348f780
973.1 kB Preview Download

Additional details

Identifiers

Patent application number
US 91345910 A
Patent number
US 2011/0046211 A1
Other
oai:uchicago.tind.io:9117

Dates

Patent filed
2010-10-27

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Radiation and Cellular Oncology, Surgery, Ben May Department for Cancer Research